Zhejiang Yatai Pharmaceutical Co Ltd
002370
Company Profile
Business description
Zhejiang Yatai Pharmaceutical Co Ltd is a China-based company engaged in the research, production, and sales of pharmaceutical drugs. Its product portfolio includes tablets, hard capsules, transdermal patches, freeze-dried powder injections, powder injections, azithromycin, roxithromycin and other products. The company sells its products both in China and other international countries.
Contact
No. 1152, Yunji Road
Keqiao District, Zhejiang province
Shaoxing312030
CHNT: +86 57584815472
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
529
Stocks News & Analysis
stocks
Chart of the Week: Soft earnings growth outlook for Australian banks
The latest take from our equity research analysts.
stocks
Coca-Cola earnings: Billion-dollar brands and consumer engagement remain growth priorities
Despite macro and geopolitical challenges, Coca-Cola managed to increase sales in line with its long-term target.
stocks
Unwarranted drop in ASX share
Jittery investors misinterpret an audit for an existential crisis.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,281.80 | 97.30 | 1.06% |
| CAC 40 | 8,313.24 | 14.64 | -0.18% |
| DAX 40 | 24,880.41 | 107.44 | -0.43% |
| Dow JONES (US) | 50,145.31 | 42.83 | -0.09% |
| FTSE 100 | 10,479.39 | 125.55 | 1.21% |
| HKSE | 27,266.38 | 83.23 | 0.31% |
| NASDAQ | 23,006.30 | 96.17 | -0.42% |
| Nikkei 225 | 57,650.54 | 1,286.60 | 2.28% |
| NZX 50 Index | 13,507.28 | 60.91 | 0.45% |
| S&P 500 | 6,941.45 | 0.36 | -0.01% |
| S&P/ASX 200 | 9,014.80 | 98.80 | 1.11% |
| SSE Composite Index | 4,131.98 | 3.61 | 0.09% |